Taken together, PAPP-A seems to confer worse survival in breast cancers in general, an effect which may be amplified by the high levels of circulating PAPP-A during pregnancy, resulting in the observed increased risk of disease recurrence in that context. Here, PAPPA is linked to breast cancer.